Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PROTAC-DB 2.0: an updated database of PROTACs
Gaoqi Weng, Xuanyan Cai, Dongsheng Cao, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1367-D1372
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Targeted protein degradation via intramolecular bivalent glues
Oliver Hsia, Matthias Hinterndorfer, Angus D. Cowan, et al.
Nature (2024) Vol. 627, Iss. 8002, pp. 204-211
Open Access | Times Cited: 72
Advancing Strategies for Proteolysis-Targeting Chimera Design
Minglei Li, Ying Zhi, Bo Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2308-2329
Closed Access | Times Cited: 45
Proteome-scale discovery of protein degradation and stabilization effectors
Juline Poirson, Hanna Cho, Akashdeep Dhillon, et al.
Nature (2024) Vol. 628, Iss. 8009, pp. 878-886
Closed Access | Times Cited: 24
Characteristic roadmap of linker governs the rational design of PROTACs
Yawen Dong, Tingting Ma, Ting Xu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4266-4295
Open Access | Times Cited: 22
Exploring the chemical space of orally bioavailable PROTACs
Giulia Apprato, Vasanthanathan Poongavanam, Diego García Jiménez, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103917-103917
Open Access | Times Cited: 17
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Current advances and development strategies of orally bioavailable PROTACs
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 35
Biophysical and Computational Approaches to Study Ternary Complexes: A ‘Cooperative Relationship’ to Rationalize Targeted Protein Degradation
Jake A. Ward, Carles Perez‐Lopez, Cristina Mayor‐Ruiz
ChemBioChem (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 33
A beginner’s guide to current synthetic linker strategies towards VHL-recruiting PROTACs
Nikol A. Zografou-Barredo, Alex J. Hallatt, J. S. JUN. RICCI, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 88-89, pp. 117334-117334
Open Access | Times Cited: 31
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design
Dazhao Mi, Yuzhan Li, Haijun Gu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115444-115444
Closed Access | Times Cited: 27
Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods
Barmak Mostofian, Holli‐Joi Martin, Asghar M. Razavi, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 17, pp. 5408-5432
Open Access | Times Cited: 27
Research in the Field of Drug Design and Development
Grażyna Biała, Ewa Kędzierska, Marta Kruk-Słomka, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1283-1283
Open Access | Times Cited: 27
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 24
Proactive and reactive roles of TGF-β in cancer
Nick A. Kuburich, Thiru Sabapathy, Breanna R. Demestichas, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 120-139
Open Access | Times Cited: 22
RediscMol: Benchmarking Molecular Generation Models in Biological Properties
Gaoqi Weng, Huifeng Zhao, Dou Nie, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1533-1543
Closed Access | Times Cited: 9
Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders
Felix Feller, Irina Honin, Martina Miranda, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Lisha Wang, Sooram Banesh, Rajnish Kumar, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
Yujeong Moon, Seong Ik Jeon, Man Kyu Shim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 411-411
Open Access | Times Cited: 21
How many kinases are druggable? A review of our current understanding
Brian Anderson, Peter Rosston, Han Wee Ong, et al.
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1331-1363
Open Access | Times Cited: 20
Targeted protein degradation via intramolecular bivalent glues
Oliver Hsia, Matthias Hinterndorfer, Angus D. Cowan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 19
3D based generative PROTAC linker design with reinforcement learning
Baiqing Li, Ting Ran, Hongming Chen
Briefings in Bioinformatics (2023) Vol. 24, Iss. 5
Closed Access | Times Cited: 18
FFLOM: A Flow-Based Autoregressive Model for Fragment-to-Lead Optimization
Jieyu Jin, Dong Wang, Guqin Shi, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10808-10823
Closed Access | Times Cited: 17
Targeted protein degradation in drug development: Recent advances and future challenges
Jian H. Song, Mingzheng Hu, Jun Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115839-115839
Closed Access | Times Cited: 17
Recent progress in degradation of membrane proteins by PROTACs and alternative targeted protein degradation techniques
Siyu Chen, Jingliang Cui, Haiyan Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115911-115911
Closed Access | Times Cited: 17
Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development
Mohd Danishuddin, Mohammad Sarwar Jamal, Kyoung Seob Song, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1649-1649
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top